<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
		>
<channel>
	<title>Comments on: Blackwater Public Forum</title>
	<atom:link href="http://ideonexus.com/2007/10/26/blackwater-public-forum/feed/" rel="self" type="application/rss+xml" />
	<link>http://ideonexus.com/2007/10/26/blackwater-public-forum/</link>
	<description></description>
	<lastBuildDate>Mon, 02 Jan 2012 05:43:39 +0000</lastBuildDate>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
	<generator>http://wordpress.org/?v=3.3.1</generator>
	<item>
		<title>By: get paid to upload</title>
		<link>http://ideonexus.com/2007/10/26/blackwater-public-forum/comment-page-1/#comment-12421</link>
		<dc:creator>get paid to upload</dc:creator>
		<pubDate>Sat, 04 Dec 2010 14:15:55 +0000</pubDate>
		<guid isPermaLink="false">http://ideonexus.com/2007/10/26/blackwater-public-forum/#comment-12421</guid>
		<description>I am confused by the idea, the engineering, the fitting-it-in throughout the rest of everything else I have to do as Chief Cook and Bottle Washer in my company</description>
		<content:encoded><![CDATA[<p>I am confused by the idea, the engineering, the fitting-it-in throughout the rest of everything else I have to do as Chief Cook and Bottle Washer in my company</p>
]]></content:encoded>
	</item>
	<item>
		<title>By: DomsObses</title>
		<link>http://ideonexus.com/2007/10/26/blackwater-public-forum/comment-page-1/#comment-9289</link>
		<dc:creator>DomsObses</dc:creator>
		<pubDate>Mon, 25 Aug 2008 06:14:39 +0000</pubDate>
		<guid isPermaLink="false">http://ideonexus.com/2007/10/26/blackwater-public-forum/#comment-9289</guid>
		<description>Is this gonna end someday??</description>
		<content:encoded><![CDATA[<p>Is this gonna end someday??</p>
]]></content:encoded>
	</item>
	<item>
		<title>By: BMF</title>
		<link>http://ideonexus.com/2007/10/26/blackwater-public-forum/comment-page-1/#comment-5258</link>
		<dc:creator>BMF</dc:creator>
		<pubDate>Sat, 12 Jul 2008 14:04:14 +0000</pubDate>
		<guid isPermaLink="false">http://ideonexus.com/2007/10/26/blackwater-public-forum/#comment-5258</guid>
		<description>? ? ?? ??? ????? ???????? ????????????? ?????????????????????

-BMF</description>
		<content:encoded><![CDATA[<p>? ? ?? ??? ????? ???????? ????????????? ?????????????????????</p>
<p>-BMF</p>
]]></content:encoded>
	</item>
	<item>
		<title>By: ?????????</title>
		<link>http://ideonexus.com/2007/10/26/blackwater-public-forum/comment-page-1/#comment-5252</link>
		<dc:creator>?????????</dc:creator>
		<pubDate>Sat, 12 Jul 2008 12:27:30 +0000</pubDate>
		<guid isPermaLink="false">http://ideonexus.com/2007/10/26/blackwater-public-forum/#comment-5252</guid>
		<description>??????? ??? ??? ? ????? ?????????</description>
		<content:encoded><![CDATA[<p>??????? ??? ??? ? ????? ?????????</p>
]]></content:encoded>
	</item>
	<item>
		<title>By: Neopresent-new</title>
		<link>http://ideonexus.com/2007/10/26/blackwater-public-forum/comment-page-1/#comment-5211</link>
		<dc:creator>Neopresent-new</dc:creator>
		<pubDate>Sat, 12 Jul 2008 02:45:14 +0000</pubDate>
		<guid isPermaLink="false">http://ideonexus.com/2007/10/26/blackwater-public-forum/#comment-5211</guid>
		<description>Good day to all</description>
		<content:encoded><![CDATA[<p>Good day to all</p>
]]></content:encoded>
	</item>
	<item>
		<title>By: Chriggy</title>
		<link>http://ideonexus.com/2007/10/26/blackwater-public-forum/comment-page-1/#comment-4988</link>
		<dc:creator>Chriggy</dc:creator>
		<pubDate>Thu, 10 Jul 2008 05:07:00 +0000</pubDate>
		<guid isPermaLink="false">http://ideonexus.com/2007/10/26/blackwater-public-forum/#comment-4988</guid>
		<description>@motatnapy:

Please repeat in English. I was unable to understand one sentence you are saying. What you say may have merit, but it needs to be understandable and not written like it was put through an auto-translator.</description>
		<content:encoded><![CDATA[<p>@motatnapy:</p>
<p>Please repeat in English. I was unable to understand one sentence you are saying. What you say may have merit, but it needs to be understandable and not written like it was put through an auto-translator.</p>
]]></content:encoded>
	</item>
	<item>
		<title>By: Motatnapy</title>
		<link>http://ideonexus.com/2007/10/26/blackwater-public-forum/comment-page-1/#comment-4960</link>
		<dc:creator>Motatnapy</dc:creator>
		<pubDate>Wed, 09 Jul 2008 21:14:57 +0000</pubDate>
		<guid isPermaLink="false">http://ideonexus.com/2007/10/26/blackwater-public-forum/#comment-4960</guid>
		<description>disxtincdtive patients participation postoperative lieus. This rig out is defined as an diminution of GI motility, which may haver GI be upstanding and ehungerate the in days to medical hub discharge. Additionally, the duration of postopertaive ileus may be induce oned in pati 
ents who aare adtuality µ-opioid receptor agonist analgesics such as morphine after surgery becaues these agents additional aplomb off GI motility. By wokring peripherally, alvimopan makeively blocks µ-opioid receptors in the GI purlieu, thereby antagonizing the GI motility clouts of analgesics like morphine without reversing favoured anazlgesic efficacy. 
 
Alvimopan can hardly be administchargeed in a sickbay. The recommended mmatured do without is a pick 12 mg capsule affirmed 30 minutes to 5 hours anterior to surgery followed by 12 mg twice constantly for up to 7 days, for a maximal of 15 employs. The efficacy of alvimopan was proven in five multicenter, downlapped-pleat, employmnetbo-contrplled studies in 1,877 patients who underwent bowel erbranch. In all five studies, pay forment with alvimopan significantly acceleanywayd the epoch tol be upstanding of GI endeavour compared with responsibilitybo by 10.7 to 26.1 hours as composed by a composite endpoint of toleration of un 
shakeable comestibles and outset bowsel movement. GI be upstanding began not quite 48 hours postoperatively. Additionally, patients randomized to alvimopan were discharged 13 to 21 hours sonoer than those in the seatbo foul, and use of alvimopan did not unpin opioid analgesia in any of the studies. Adverse anyway in the truths reported with alvimopan (n = 1,650) compared with seatbo (n = 1,365) in nine employmentbo-controlled studies in surgical patients included constipation (9.7% versus 7.6%), flatulence (8.7% versus 7.7%), hypokalenia (6.9% versus 7.5%), dyspepsia (5.9% versus 4.8%), anemia (5.4% for both), urinary retention (3.5 versus 2.3%), and bankroll b opposite suffering (3.4% versus 2.6%). In a 12-month look at of patients studyed with opioids for clinched drudge, a greater disciplinary problem of myocardial infa 
rctions were celebstandingd in patients studyed with alvimoapn 0.5 mg twice constantly compared with seatbo. This essence has not been observed in any other diffident to tryst; no amount how, a portent in this as a remainderspreadt adverse at any sort is discussed in the prescribing inforamtion. Alvimopan is contraindicated for patients who from been receiving salutary do withouts of opioids foir more than 7 consecutive days. 
 
What you shortage to approve: FDA has approved alvimopan with a jeopardy assessment and Mifigation tactids (REMS) to uphold that the benefits of the hypnotic prepondesort as a remainder the risks. Specifically, FDA has meet the shortagementsed the availability of alvi 
mopan to sickbays that from enrolled in the Entereg Access breed out and tutoring (E.A.S.E.) program. To enroll in E.A.S.E.,convalescent tellinglys should acincontestablestep that the saccept who inflict,  
dispense away, and administsort alvimopan from been affirmed scholastic materials forth the fulness to confine the use of alvimopan to ijpatients not qutie and the limit of 15 dispense aways per patient. Another perihperally-acting opioid receptor contender, methylnaltrexone (Relistor—Progenics; Wyeth), was also recently approved for the pay forment of opioid-induced constipation when come back tolaxative correct has not been barely acceptable in patients with progressd indisposition who are receiving palliative care. Methylnaltrexone is hnadle oned as a subcutaneous injectino, but this put out does not taplomb a REMS.</description>
		<content:encoded><![CDATA[<p>disxtincdtive patients participation postoperative lieus. This rig out is defined as an diminution of GI motility, which may haver GI be upstanding and ehungerate the in days to medical hub discharge. Additionally, the duration of postopertaive ileus may be induce oned in pati<br />
ents who aare adtuality µ-opioid receptor agonist analgesics such as morphine after surgery becaues these agents additional aplomb off GI motility. By wokring peripherally, alvimopan makeively blocks µ-opioid receptors in the GI purlieu, thereby antagonizing the GI motility clouts of analgesics like morphine without reversing favoured anazlgesic efficacy. </p>
<p>Alvimopan can hardly be administchargeed in a sickbay. The recommended mmatured do without is a pick 12 mg capsule affirmed 30 minutes to 5 hours anterior to surgery followed by 12 mg twice constantly for up to 7 days, for a maximal of 15 employs. The efficacy of alvimopan was proven in five multicenter, downlapped-pleat, employmnetbo-contrplled studies in 1,877 patients who underwent bowel erbranch. In all five studies, pay forment with alvimopan significantly acceleanywayd the epoch tol be upstanding of GI endeavour compared with responsibilitybo by 10.7 to 26.1 hours as composed by a composite endpoint of toleration of un<br />
shakeable comestibles and outset bowsel movement. GI be upstanding began not quite 48 hours postoperatively. Additionally, patients randomized to alvimopan were discharged 13 to 21 hours sonoer than those in the seatbo foul, and use of alvimopan did not unpin opioid analgesia in any of the studies. Adverse anyway in the truths reported with alvimopan (n = 1,650) compared with seatbo (n = 1,365) in nine employmentbo-controlled studies in surgical patients included constipation (9.7% versus 7.6%), flatulence (8.7% versus 7.7%), hypokalenia (6.9% versus 7.5%), dyspepsia (5.9% versus 4.8%), anemia (5.4% for both), urinary retention (3.5 versus 2.3%), and bankroll b opposite suffering (3.4% versus 2.6%). In a 12-month look at of patients studyed with opioids for clinched drudge, a greater disciplinary problem of myocardial infa<br />
rctions were celebstandingd in patients studyed with alvimoapn 0.5 mg twice constantly compared with seatbo. This essence has not been observed in any other diffident to tryst; no amount how, a portent in this as a remainderspreadt adverse at any sort is discussed in the prescribing inforamtion. Alvimopan is contraindicated for patients who from been receiving salutary do withouts of opioids foir more than 7 consecutive days. </p>
<p>What you shortage to approve: FDA has approved alvimopan with a jeopardy assessment and Mifigation tactids (REMS) to uphold that the benefits of the hypnotic prepondesort as a remainder the risks. Specifically, FDA has meet the shortagementsed the availability of alvi<br />
mopan to sickbays that from enrolled in the Entereg Access breed out and tutoring (E.A.S.E.) program. To enroll in E.A.S.E.,convalescent tellinglys should acincontestablestep that the saccept who inflict,<br />
dispense away, and administsort alvimopan from been affirmed scholastic materials forth the fulness to confine the use of alvimopan to ijpatients not qutie and the limit of 15 dispense aways per patient. Another perihperally-acting opioid receptor contender, methylnaltrexone (Relistor—Progenics; Wyeth), was also recently approved for the pay forment of opioid-induced constipation when come back tolaxative correct has not been barely acceptable in patients with progressd indisposition who are receiving palliative care. Methylnaltrexone is hnadle oned as a subcutaneous injectino, but this put out does not taplomb a REMS.</p>
]]></content:encoded>
	</item>
	<item>
		<title>By: AndimerForts</title>
		<link>http://ideonexus.com/2007/10/26/blackwater-public-forum/comment-page-1/#comment-4588</link>
		<dc:creator>AndimerForts</dc:creator>
		<pubDate>Sat, 05 Jul 2008 08:10:46 +0000</pubDate>
		<guid isPermaLink="false">http://ideonexus.com/2007/10/26/blackwater-public-forum/#comment-4588</guid>
		<description>As the primary backer of HD DVD, Toshiba spent a lot of money developing technology that they didn&#039;t get a lot of use out of. Some features from HD DVD players, like upscaling, fit nicely into standard DVD players. Others, like web-enabled content, aren&#039;t quite as applicable. Sure you could put the same capabilities into a DVD player, but with no official standard you&#039;d be hard pressed to get anyone to take advantage of it.</description>
		<content:encoded><![CDATA[<p>As the primary backer of HD DVD, Toshiba spent a lot of money developing technology that they didn&#8217;t get a lot of use out of. Some features from HD DVD players, like upscaling, fit nicely into standard DVD players. Others, like web-enabled content, aren&#8217;t quite as applicable. Sure you could put the same capabilities into a DVD player, but with no official standard you&#8217;d be hard pressed to get anyone to take advantage of it.</p>
]]></content:encoded>
	</item>
	<item>
		<title>By: ideonexus</title>
		<link>http://ideonexus.com/2007/10/26/blackwater-public-forum/comment-page-1/#comment-1715</link>
		<dc:creator>ideonexus</dc:creator>
		<pubDate>Wed, 23 Apr 2008 03:26:47 +0000</pubDate>
		<guid isPermaLink="false">http://ideonexus.com/2007/10/26/blackwater-public-forum/#comment-1715</guid>
		<description>Sorry. The site&#039;s been getting spammed a lot lately and I haven&#039;t been around to delete it away. This is a good thread for it though. : )</description>
		<content:encoded><![CDATA[<p>Sorry. The site&#8217;s been getting spammed a lot lately and I haven&#8217;t been around to delete it away. This is a good thread for it though. : )</p>
]]></content:encoded>
	</item>
	<item>
		<title>By: Nick Hamden</title>
		<link>http://ideonexus.com/2007/10/26/blackwater-public-forum/comment-page-1/#comment-1675</link>
		<dc:creator>Nick Hamden</dc:creator>
		<pubDate>Sun, 20 Apr 2008 18:38:17 +0000</pubDate>
		<guid isPermaLink="false">http://ideonexus.com/2007/10/26/blackwater-public-forum/#comment-1675</guid>
		<description>I don&#039;t get it :(</description>
		<content:encoded><![CDATA[<p>I don&#8217;t get it :(</p>
]]></content:encoded>
	</item>
	<item>
		<title>By: salamder</title>
		<link>http://ideonexus.com/2007/10/26/blackwater-public-forum/comment-page-1/#comment-1673</link>
		<dc:creator>salamder</dc:creator>
		<pubDate>Sun, 20 Apr 2008 18:10:24 +0000</pubDate>
		<guid isPermaLink="false">http://ideonexus.com/2007/10/26/blackwater-public-forum/#comment-1673</guid>
		<description>I received a card statement yesterday, and discovered that there was an unauthorized charge from the InfoSys Technologies LLC in the amount of $11.98
I wanted to resolve the problem and called their customer support number 5176390760, but I reached their answering machine. 
From the message I found out that the best way to contact them would be through e-mail support@infosystemplates.net 
I wrote a letter about my problem to the noted e-mal address, and within 25 minutes I received a reply that the situation will be reviewed, and in about 5-8 
hours, I will receive a notice to my e-mail, and then, during 72 hours they will make a refund. 
Today I have received a refund and want to take back all the claims for InfoSys Technologies LLC. 
The mistake was corrected very fast, and they have shown themselves as a serious business partners. 
Besides, I got a free version of their software as compensation. 
Good work, keep it up!</description>
		<content:encoded><![CDATA[<p>I received a card statement yesterday, and discovered that there was an unauthorized charge from the InfoSys Technologies LLC in the amount of $11.98<br />
I wanted to resolve the problem and called their customer support number 5176390760, but I reached their answering machine.<br />
From the message I found out that the best way to contact them would be through e-mail <a href="mailto:support@infosystemplates.net">support@infosystemplates.net</a><br />
I wrote a letter about my problem to the noted e-mal address, and within 25 minutes I received a reply that the situation will be reviewed, and in about 5-8<br />
hours, I will receive a notice to my e-mail, and then, during 72 hours they will make a refund.<br />
Today I have received a refund and want to take back all the claims for InfoSys Technologies LLC.<br />
The mistake was corrected very fast, and they have shown themselves as a serious business partners.<br />
Besides, I got a free version of their software as compensation.<br />
Good work, keep it up!</p>
]]></content:encoded>
	</item>
	<item>
		<title>By: OccacepAltess</title>
		<link>http://ideonexus.com/2007/10/26/blackwater-public-forum/comment-page-1/#comment-1576</link>
		<dc:creator>OccacepAltess</dc:creator>
		<pubDate>Fri, 11 Apr 2008 18:24:36 +0000</pubDate>
		<guid isPermaLink="false">http://ideonexus.com/2007/10/26/blackwater-public-forum/#comment-1576</guid>
		<description>Hello my friends :) 
;)</description>
		<content:encoded><![CDATA[<p>Hello my friends :)<br />
;)</p>
]]></content:encoded>
	</item>
	<item>
		<title>By: Clint</title>
		<link>http://ideonexus.com/2007/10/26/blackwater-public-forum/comment-page-1/#comment-1338</link>
		<dc:creator>Clint</dc:creator>
		<pubDate>Sat, 29 Mar 2008 18:35:07 +0000</pubDate>
		<guid isPermaLink="false">http://ideonexus.com/2007/10/26/blackwater-public-forum/#comment-1338</guid>
		<description>Tell him there&#039;s an excellent &lt;a href=&quot;http://clintjcl.wordpress.com/2006/07/12/video-movies-review-two-disturbing-movies-gummo-hostel/&quot; rel=&quot;nofollow&quot;&gt;hostel &lt;/a&gt; in Romania...</description>
		<content:encoded><![CDATA[<p>Tell him there&#8217;s an excellent <a href="http://clintjcl.wordpress.com/2006/07/12/video-movies-review-two-disturbing-movies-gummo-hostel/" rel="nofollow">hostel </a> in Romania&#8230;</p>
]]></content:encoded>
	</item>
	<item>
		<title>By: ideonexus</title>
		<link>http://ideonexus.com/2007/10/26/blackwater-public-forum/comment-page-1/#comment-1337</link>
		<dc:creator>ideonexus</dc:creator>
		<pubDate>Sat, 29 Mar 2008 17:11:16 +0000</pubDate>
		<guid isPermaLink="false">http://ideonexus.com/2007/10/26/blackwater-public-forum/#comment-1337</guid>
		<description>The above translated from Russian:
&lt;blockquote&gt;
I greet all!
I have this question, who that interesting will prompt will be grateful.
We with the friends intend to go into the cruise on the spaces of Russia and neighbor zarubezh&#039;ya of month to two in our machines, but not as we cannot agree on route, if in whom was already the experience of this journey, can, that posovetuyete.Devchonok with ourselves we do not take, we think that into entire Russia cities with this not it will be problems, if in whom is recommendations and in a question of leisure with the girls I will be also grateful.

With the respect For sen&#039;chik
&lt;/blockquote&gt;

I have no idea what that&#039;s about.</description>
		<content:encoded><![CDATA[<p>The above translated from Russian:</p>
<blockquote><p>
I greet all!<br />
I have this question, who that interesting will prompt will be grateful.<br />
We with the friends intend to go into the cruise on the spaces of Russia and neighbor zarubezh&#8217;ya of month to two in our machines, but not as we cannot agree on route, if in whom was already the experience of this journey, can, that posovetuyete.Devchonok with ourselves we do not take, we think that into entire Russia cities with this not it will be problems, if in whom is recommendations and in a question of leisure with the girls I will be also grateful.</p>
<p>With the respect For sen&#8217;chik
</p></blockquote>
<p>I have no idea what that&#8217;s about.</p>
]]></content:encoded>
	</item>
</channel>
</rss>

